New Findings Open Doors for Rational Lung Cancer Treatment Strategies

ALK with crizotinib

In a study published Tuesday in the American Association for Cancer Research’s journal Clinical Cancer Research, researchers identified two novel mutations that cause resistance to alectinib, a drug that belongs …

Read More